Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation

Clinical Immunology

Volumn 117, Issue 3, 2005, Pages 231-237

  Blaeser, Frank ^a   Kelly, Michael ^b   Siegrist, Karen ^c   Storch, Gregory A ^c   Buller, Richard S ^c   Whitlock, Jessica ^d   Truong, Nga ^d   Chatila, Talal A ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anemia; CD40 ligand; Parvovirus B19; X linked hyper IgM immunodeficiency

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT GAMMA INTERFERON;

ADOLESCENT; ANEMIA; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CASE REPORT; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; IMMUNE DEFICIENCY; MALE; MUTAGENESIS; NONSENSE MUTATION; PARVOVIRUS; PARVOVIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TH1 CELL; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ANEMIA; CD40 LIGAND; DRUG THERAPY, COMBINATION; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOGLOBULIN G; INTERFERON TYPE II; MALE; MUTATION; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; SIGNAL TRANSDUCTION; TREATMENT FAILURE;

EID: 29344462227     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.08.005     Document Type: Article

References (33)

1. J. Levy, T. Espanol-Boren, C. Thomas, and A. Fischer Clinical spectrum of X-linked hyper-IgM syndrome J. Pediatr. 131 1997 47 54
2. K.C. Gilmour, D. Walshe, S. Heath, and G. Monaghan Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM Mol. Pathol. 56 2003 256 262
3. J.A. Winkelstein, M.C. Marino, H. Ochs, and R. Fuleihan The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients Medicine (Baltimore) 82 2003 373 384
4. R. Fuleihan, N. Ramesh, R. Loh, and H. Jabara Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM Proc. Natl. Acad. Sci. U. S. A. 90 1993 2170 2173
5. A. Aruffo, M. Farrington, D. Hollenbaugh, and X. Li The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome Cell 72 1993 291 300
6. R.C. Allen, R.J. Armitage, M.E. Conley, and H. Rosenblatt CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome Science 259 1993 990 993
7. J.P. DiSanto, J.Y. Bonnefoy, J.F. Gauchat, and A. Fischer CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM Nature 361 1993 541 543
8. U. Korthauer, D. Graf, H.W. Mages, and F. Briere Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM Nature 361 1993 539 541
9. R.J. Noelle CD40 and its ligand in host defense Immunity 4 1996 415 419
10. G.A. Bishop, and B.S. Hostager The CD40-CD154 interaction in B cell-T cell liaisons Cytokine Growth Factor Rev. 14 2003 297 309
11. I.S. Grewal, and R.A. Flavell CD40 and CD154 in cell-mediated immunity Annu. Rev. Immunol. 16 1998 111 135
12. S.A. Quezada, L.Z. Jarvinen, E.F. Lind, and R.J. Noelle CD40/CD154 interactions at the interface of tolerance and immunity Annu. Rev. Immunol. 22 2004 307 328
13. N.S. Young, and K.E. Brown Parvovirus B19 N. Engl. J. Med. 350 2004 586 597
14. G.J. Kurtzman, K. Ozawa, B. Cohen, and G. Hanson Chronic bone marrow failure due to persistent B19 parvovirus infection N. Engl. J. Med. 317 1987 287 294
15. F. Blaeser, N. Ho, R. Prywes, and T.A. Chatila Ca(2+)-dependent gene expression mediated by MEF2 transcription factors J. Biol. Chem. 275 2000 197 209
16. J.S. Sevall, J. Ritenhous, and J.B. Peter Laboratory diagnosis of parvovirus B19 infection J. Clin. Lab. Anal. 6 1992 171 175
17. W.C. Koch, and S.P. Adler Detection of human parvovirus B19 DNA by using the polymerase chain reaction J. Clin. Microbiol. 28 1990 65 69
18. K. Seyama, R. Kobayashi, H. Hasle, and A.J. Apter Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome J. Infect. Dis. 178 1998 318 324
19. M. Kozak Constraints on reinitiation of translation in mammals Nucleic. Acids Res. 29 2001 5226 5232
20. K. Agematsu, H. Nagumo, K. Shinozaki, and S. Hokibara Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome J. Clin. Invest. 102 1998 853 860
21. U. Klein, K. Rajewsky, and R. Kuppers Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells J. Exp. Med. 188 1998 1679 1689
22. B. Piqueras, C. Lavenu-Bombled, L. Galicier, and F. Bergeron-van der Cruyssen Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects J. Clin. Immunol. 23 2003 385 400
23. K. Warnatz, A. Denz, R. Drager, and M. Braun Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease Blood 99 2002 1544 1551
24. A. Jain, T.P. Atkinson, P.E. Lipsky, and J.E. Slater Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome J. Clin. Invest. 103 1999 1151 1158
25. E. Stuber, W. Strober, and M. Neurath Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion J. Exp. Med. 183 1996 693 698
26. M. Armant, R. Armitage, N. Boiani, and G. Delespesse Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: involvement in interleukin-2-induced interleukin-12 and interferon-gamma production Eur. J. Immunol. 26 1996 1430 1434
27. X. Peng, A. Kasran, P.A. Warmerdam, and M. de Boer Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production Eur. J. Immunol. 26 1996 1621 1627
28. S.E. Dorman, G. Uzel, J. Roesler, and J.S. Bradley Viral infections in interferon-gamma receptor deficiency J. Pediatr. 135 1999 640 643
29. T.M. Foy, J.D. Laman, J.A. Ledbetter, and A. Aruffo gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory J. Exp. Med. 180 1994 157 163
30. C. Ahonen, E. Manning, L.D. Erickson, and B. O'Connor The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells Nat. Immunol. 3 2002 451 456
31. S. Ferrari, S. Giliani, A. Insalaco, and A. Al-Ghonaium Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM Proc. Natl. Acad. Sci. U. S. A. 98 2001 12614 12619
32. A. Jain, C.A. Ma, S. Liu, and M. Brown Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia Nat. Immunol. 2 2001 223 228
33. P. Revy, T. Muto, Y. Levy, and F. Geissmann Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2) Cell 102 2000 565 575